Metabolic restaging of hepatocellular carcinoma using whole-body 18F-FDG PET/CT

doi:10.4254/wjh.v1.i1.90

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6448)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

537

HTML

5055

Figures (1-4)

487

Tables (1-2)

369

Sum=6448

Oct 31, 2009 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Hepatol. Oct 31, 2009; 1(1): 90-97
Published online Oct 31, 2009. doi: 10.4254/wjh.v1.i1.90

Full Size Figure Download Figure

Figure 1 A 38-year man, who had TACE 1 mo before, underwent PET/CT to monitor response to the treatment. Contrast-enhanced arterial-phase axial CT image showed the mass with partial accumulation of iodized oil in the right lobe of the liver (arrows, A, B). A filling defect was detected in the left branch during the portal phases (arrow, C). PET and PET/CT fused images (arrows, D, E and F) revealed residual viable tumor and a highly metabolically active tumor thrombus in the left branch of the portal vein.

Citation: Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Metabolic restaging of hepatocellular carcinoma using whole-body ¹⁸F-FDG PET/CT. World J Hepatol 2009; 1(1): 90-97
URL: https://www.wjgnet.com/1948-5182/full/v1/i1/90.htm
DOI: https://dx.doi.org/10.4254/wjh.v1.i1.90